Literature DB >> 24706938

The dichotomy of p53 regulation by noncoding RNAs.

Qipan Deng1, Lindsey Becker1, Xiaodong Ma1, Xiaoming Zhong2, Ken Young3, Kenneth Ramos1, Yong Li4.   

Abstract

The p53 tumor suppressor gene is the most frequently mutated gene in cancer. Significant progress has been made to discern the importance of p53 in coordinating cellular responses to DNA damage, oncogene activation, and other stresses. Noncoding RNAs are RNA molecules functioning without being translated into proteins. In this work, we discuss the dichotomy of p53 regulation by noncoding RNAs with four unconventional questions. First, is overexpression of microRNAs responsible for p53 inactivation in the absence of p53 mutation? Second, are there somatic mutations in the noncoding regions of the p53 gene? Third, is there a germline mutant in the noncoding regions of the p53 gene that predisposes carriers to cancer? Fourth, can p53 activation mediated by a noncoding RNA mutation cause cancer? This work highlights the prominence of noncoding RNAs in p53 dysregulation and tumorigenesis.
© The Author (2014). Published by Oxford University Press on behalf of Journal of Molecular Cell Biology, IBCB, SIBS, CAS. All rights reserved.

Entities:  

Keywords:  3′UTR; activation; mutation; noncoding RNA; p53; polymorphism; ribosomopathies

Mesh:

Substances:

Year:  2014        PMID: 24706938      PMCID: PMC4034729          DOI: 10.1093/jmcb/mju017

Source DB:  PubMed          Journal:  J Mol Cell Biol        ISSN: 1759-4685            Impact factor:   6.216


  72 in total

1.  A functional germline variant in the P53 polyadenylation signal and risk of esophageal squamous cell carcinoma.

Authors:  Liqing Zhou; Qipeng Yuan; Ming Yang
Journal:  Gene       Date:  2012-07-16       Impact factor: 3.688

2.  Rare TP53 genetic variant associated with glioma risk and outcome.

Authors:  Kathleen M Egan; L Burton Nabors; Jeffrey J Olson; Alvaro N Monteiro; James E Browning; Melissa H Madden; Reid C Thompson
Journal:  J Med Genet       Date:  2012-06-15       Impact factor: 6.318

3.  Impact of deleterious passenger mutations on cancer progression.

Authors:  Christopher D McFarland; Kirill S Korolev; Gregory V Kryukov; Shamil R Sunyaev; Leonid A Mirny
Journal:  Proc Natl Acad Sci U S A       Date:  2013-02-06       Impact factor: 11.205

4.  Tobacco smoking and risk of multiple myeloma: a meta-analysis of 40 observational studies.

Authors:  Theodora Psaltopoulou; Theodoros N Sergentanis; Nick Kanellias; Prodromos Kanavidis; Evangelos Terpos; Meletios A Dimopoulos
Journal:  Int J Cancer       Date:  2012-10-29       Impact factor: 7.396

Review 5.  p53 mutations in cancer.

Authors:  Patricia A J Muller; Karen H Vousden
Journal:  Nat Cell Biol       Date:  2013-01       Impact factor: 28.824

6.  No association between cigarette smoking and incidence of plasma cell myeloma: a meta-analysis of 17 observational studies.

Authors:  Jorge J Castillo; Pradeep K Dhami; Stephanie Curry; Keith Brennan
Journal:  Am J Hematol       Date:  2012-05-06       Impact factor: 10.047

7.  Mutational profile and prognostic significance of TP53 in diffuse large B-cell lymphoma patients treated with R-CHOP: report from an International DLBCL Rituximab-CHOP Consortium Program Study.

Authors:  Zijun Y Xu-Monette; Lin Wu; Carlo Visco; Yu Chuan Tai; Alexander Tzankov; Wei-min Liu; Santiago Montes-Moreno; Karen Dybkaer; April Chiu; Attilio Orazi; Youli Zu; Govind Bhagat; Kristy L Richards; Eric D Hsi; X Frank Zhao; William W L Choi; Xiaoying Zhao; J Han van Krieken; Qin Huang; Jooryung Huh; Weiyun Ai; Maurilio Ponzoni; Andrés J M Ferreri; Fan Zhou; Brad S Kahl; Jane N Winter; Wei Xu; Jianyong Li; Ronald S Go; Yong Li; Miguel A Piris; Michael B Møller; Roberto N Miranda; Lynne V Abruzzo; L Jeffrey Medeiros; Ken H Young
Journal:  Blood       Date:  2012-09-05       Impact factor: 22.113

8.  Off-target effect of endogenous siRNA derived from RMRP in human cells.

Authors:  Yoshiko Maida; Satoru Kyo; Timo Lassmann; Yoshihide Hayashizaki; Kenkichi Masutomi
Journal:  Int J Mol Sci       Date:  2013-04-29       Impact factor: 5.923

9.  A systematic screen reveals MicroRNA clusters that significantly regulate four major signaling pathways.

Authors:  Lindsey E Becker; Zhongxin Lu; Weiqun Chen; Wei Xiong; Maiying Kong; Yong Li
Journal:  PLoS One       Date:  2012-11-08       Impact factor: 3.240

10.  Low penetrance susceptibility to glioma is caused by the TP53 variant rs78378222.

Authors:  V Enciso-Mora; F J Hosking; A L Di Stefano; D Zelenika; S Shete; P Broderick; A Idbaih; J-Y Delattre; K Hoang-Xuan; Y Marie; M Labussière; A Alentorn; P Ciccarino; M Rossetto; G Armstrong; Y Liu; K Gousias; J Schramm; C Lau; S J Hepworth; M Schoemaker; K Strauch; M Müller-Nurasyid; S Schreiber; A Franke; S Moebus; L Eisele; A Swerdlow; M Simon; M Bondy; M Lathrop; M Sanson; R S Houlston
Journal:  Br J Cancer       Date:  2013-04-09       Impact factor: 7.640

View more
  8 in total

1.  An integrative transcriptomic analysis reveals p53 regulated miRNA, mRNA, and lncRNA networks in nasopharyngeal carcinoma.

Authors:  Zhaojian Gong; Qian Yang; Zhaoyang Zeng; Wenling Zhang; Xiayu Li; Xuyu Zu; Hao Deng; Pan Chen; Qianjin Liao; Bo Xiang; Ming Zhou; Xiaoling Li; Yong Li; Wei Xiong; Guiyuan Li
Journal:  Tumour Biol       Date:  2015-10-13

2.  The regulation of the p53/MDM2 feedback loop by microRNAs.

Authors:  Cen Zhang; Juan Liu; Xiaolong Wang; Zhaohui Feng
Journal:  RNA Dis       Date:  2015

3.  The role of miR-200a in mammalian epithelial cell transformation.

Authors:  Lindsey E Becker; Apana Agha L Takwi; Zhongxin Lu; Yong Li
Journal:  Carcinogenesis       Date:  2014-09-19       Impact factor: 4.944

4.  MicroRNA-375 Is Induced in Cisplatin Nephrotoxicity to Repress Hepatocyte Nuclear Factor 1-β.

Authors:  Jielu Hao; Qiang Lou; Qingqing Wei; Shuqin Mei; Lin Li; Guangyu Wu; Qing-Sheng Mi; Changlin Mei; Zheng Dong
Journal:  J Biol Chem       Date:  2017-01-24       Impact factor: 5.157

5.  The dynamic behavior of Ect2 in response to DNA damage.

Authors:  Dan He; Jinnan Xiang; Baojie Li; Huijuan Liu
Journal:  Sci Rep       Date:  2016-04-14       Impact factor: 4.379

Review 6.  Regulation of Mutant p53 Protein Expression.

Authors:  Reshma Vijayakumaran; Kah Hin Tan; Panimaya Jeffreena Miranda; Sue Haupt; Ygal Haupt
Journal:  Front Oncol       Date:  2015-12-17       Impact factor: 6.244

7.  Long non-coding RNA Malat1 promotes neurite outgrowth through activation of ERK/MAPK signalling pathway in N2a cells.

Authors:  Lei Chen; Peimin Feng; Xi Zhu; Shixu He; Jialan Duan; Dong Zhou
Journal:  J Cell Mol Med       Date:  2016-07-04       Impact factor: 5.310

Review 8.  Role of tumor suppressor p53 and micro-RNA interplay in multiple myeloma pathogenesis.

Authors:  Jahangir Abdi; Nasrin Rastgoo; Lihong Li; Wenming Chen; Hong Chang
Journal:  J Hematol Oncol       Date:  2017-10-26       Impact factor: 17.388

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.